INVESTINGAlexion to Buy Portola for $18 a Share, or $1.41 BillionBy Tony OwusuMay 5, 2020 10:42 AM EDT
PRESS RELEASESSHAREHOLDER ALERT: WeissLaw LLP Investigates Portola Pharmaceuticals, Inc.By PR NewswireMay 5, 2020 8:02 PM EDT
PRESS RELEASESAlexion To Present At The Virtual Bank Of America Securities 2020 Healthcare ConferenceBy Business WireMay 5, 2020 4:30 PM EDT
PRESS RELEASESPortola Pharmaceuticals Cancels First Quarter 2020 Financial Results Webcast And Conference Call Following Agreement To Be Acquired By AlexionBy PR NewswireMay 5, 2020 4:02 PM EDT
PRESS RELEASESALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of Portola Pharmaceuticals, Inc.By PR NewswireMay 5, 2020 3:10 PM EDT
INVESTINGAlexion to Buy Portola for $18 a Share, or $1.41 BillionBy Tony OwusuMay 5, 2020 10:42 AM EDT
PRESS RELEASESAlexion Receives CHMP Positive Opinion For ULTOMIRIS® (ravulizumab) In Atypical Hemolytic Uremic Syndrome (aHUS)By Business WireMay 1, 2020 8:30 AM EDT
INVESTINGAlexion Targets COVID-19 With Blood Disorder DrugBy Scott Van VoorhisApr 20, 2020 2:35 PM EDT
PRESS RELEASESAlexion To Report First Quarter Results And Provide Update On COVID-19 On Wednesday, May 6th, 2020By Business WireApr 9, 2020 5:25 PM EDT
PRESS RELEASESÂ Alexion Announces Upcoming Data Presentations At 72nd Annual Meeting Of The American Academy Of NeurologyBy Business WireMar 5, 2020 6:25 PM EST
PRESS RELEASESAlexion To Present At The 40th Annual Cowen Health Care ConferenceBy Business WireFeb 26, 2020 6:30 AM EST
PRESS RELEASESUPDATED TIME: Alexion Fourth Quarter And Full Year 2019 Results Conference Call At 7:30am ET On Thursday, January 30, 2020By Business WireJan 24, 2020 6:30 AM EST
PRESS RELEASESAlexion To Report Fourth Quarter And Full Year 2019 Results On Thursday, January 30, 2020By Business WireJan 17, 2020 6:30 AM EST
PRESS RELEASESAlexion Announces Planned Initiation Of Pivotal Phase 3 Study Of ULTOMIRIS® (ravulizumab) In ALSBy Business WireJan 14, 2020 8:30 AM EST
INVESTINGAlexion Rebuffs Elliott Management's Push to Sell; Stock SoarsBy Tony OwusuDec 6, 2019 3:25 PM EST
JIM CRAMERAbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning RoundBy Scott RuttNov 21, 2019 8:39 PM EST
MARKETSStocks Finish Higher as Investors Digest Mixed Boeing and Caterpillar EarningsBy Rob LenihanOct 23, 2019 4:25 PM EDT
INVESTINGAlexion Rises After Drug Developer Beats Earnings ExpectationsBy Scott Van VoorhisOct 23, 2019 10:56 AM EDT
MARKETSAlexion Pharmaceuticals to Acquire Achillion in $930 Million DealBy Brenda BouwOct 16, 2019 10:00 AM EDT
MARKETSAlexion Shares Slide After Departure of Chief Financial OfficerBy Brenda BouwSep 18, 2019 1:30 PM EDT
STOCKSAlexion Shares Decline in Wake of Amgen's Deal for OtezlaBy Scott Van VoorhisAug 26, 2019 12:02 PM EDT
